1. Home
  2. ADPT vs SPB Comparison

ADPT vs SPB Comparison

Compare ADPT & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • SPB
  • Stock Information
  • Founded
  • ADPT 2009
  • SPB 1906
  • Country
  • ADPT United States
  • SPB United States
  • Employees
  • ADPT N/A
  • SPB N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • SPB Industrial Machinery/Components
  • Sector
  • ADPT Health Care
  • SPB Miscellaneous
  • Exchange
  • ADPT Nasdaq
  • SPB Nasdaq
  • Market Cap
  • ADPT 1.4B
  • SPB 1.7B
  • IPO Year
  • ADPT 2019
  • SPB N/A
  • Fundamental
  • Price
  • ADPT $9.53
  • SPB $55.23
  • Analyst Decision
  • ADPT Buy
  • SPB Buy
  • Analyst Count
  • ADPT 6
  • SPB 5
  • Target Price
  • ADPT $9.83
  • SPB $89.80
  • AVG Volume (30 Days)
  • ADPT 2.5M
  • SPB 594.5K
  • Earning Date
  • ADPT 05-01-2025
  • SPB 05-08-2025
  • Dividend Yield
  • ADPT N/A
  • SPB 3.25%
  • EPS Growth
  • ADPT N/A
  • SPB N/A
  • EPS
  • ADPT N/A
  • SPB 2.12
  • Revenue
  • ADPT $189,527,000.00
  • SPB $2,929,100,000.00
  • Revenue This Year
  • ADPT $25.00
  • SPB N/A
  • Revenue Next Year
  • ADPT $20.38
  • SPB N/A
  • P/E Ratio
  • ADPT N/A
  • SPB $27.90
  • Revenue Growth
  • ADPT 8.61
  • SPB 1.46
  • 52 Week Low
  • ADPT $2.99
  • SPB $56.50
  • 52 Week High
  • ADPT $10.28
  • SPB $96.62
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 59.79
  • SPB 34.08
  • Support Level
  • ADPT $8.50
  • SPB $56.86
  • Resistance Level
  • ADPT $9.69
  • SPB $59.04
  • Average True Range (ATR)
  • ADPT 0.41
  • SPB 1.61
  • MACD
  • ADPT -0.01
  • SPB -0.59
  • Stochastic Oscillator
  • ADPT 77.52
  • SPB 0.95

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.

Share on Social Networks: